| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d25ca02fb0e96ed0e3eb8df494020f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f664356294234e6c9aed711394a36e40 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28772b41bbdc0570aa343d78e70c55f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b902896018036f80a52eb7d6cab8452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c941d6eeba6df018fedffb4aa89e4c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e87a91e5ba1248343195ddf7ce10528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135e2c7806a943a9af1cebb5a73c3e72 |
| publicationDate |
2023-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2023277144-A1 |
| titleOfInvention |
Humanized antibody capable of binding to heg1 protein, and complex of said antibody and radioactive nuclear species |
| abstract |
The present invention provides: a humanized antibody capable of binding to HEG1 protein; and a complex of the antibody and a radioactive nuclear species. According to the present invention, a complex comprising an antibody and a radioactive nuclear species is provided, in which the antibody is a humanized antibody capable of binding to human HEG1 protein expressed in a mesothelioma cell. |
| priorityDate |
2021-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |